Established or suspected colorectal diseases
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with established or suspicious of harboring colorectal diseases
Exclusion criteria
Exclusion criteria: 1. Patients with dysphasia 2. Patients with allergy to drugs used in this study. 3. Pregnant or possible pregnant women 4. Patients who will undergo MRI 2weeks after CCE 5. Patients with present or past history of small and large bowel obstruction 6. Patients suspicious of having colorectal advanced carcinoma by tumor markers or symptoms 7. Patients inappropriate for this study by other reasons judged by investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total colonoscopy rate of CCE | — |
Secondary
| Measure | Time frame |
|---|---|
| Detectability of CCE for colorectal diseases compared with conventional colonoscopy Acceptance of CCE by a questionnaire Bowel cleansing level Adverse events of CCE | — |
Countries
Japan
Contacts
Fujita Health University School of Medicine IRB